GuideWell Clip Transcript:
October 16, 2020
Pat Geraghty
The months of living with COVID-19 have forever changed many things in our lives, including how we want to get our
healthcare. That is evident by the soaring use of virtual care services, like Teladoc Health, where we can talk to a doctor 24 hours a day from our homes, our offices, or anywhere else. Many of our members and customers quickly adapted to virtual
care for their medical needs during the pandemic. What started as a necessity soon became a choice because of the convenience of virtual health. Partnering with industry leading companies will continue to help us meet our members changing needs and
growing expectations. Thats why we are excited to be working with Livongo, a company that helps people with chronic conditions live better and healthier lives. In August, Teladoc Health and Livongo announced a merger to create the global
leader in consumer centered virtual care.
Together, they will offer some of our Florida Blue members with diabetes an enhanced end-to-end virtual care experience, all through our very own OnLife health platform. By integrating Teladocs best-in-class virtual care platform with Livongos ability to provide useful insights to members, in real time, were providing our members with a single access point for whole-person care, which
will help drive better health outcomes and lower costs. And it allows members to manage their health on their own terms. This is a great example of how three critical pieces of our enterprise, our diversified businesses, GuideWell Health, and
Florida Blue can come together to meet our members evolving needs in innovative ways, both during the pandemic and beyond.
Cautionary Note Regarding
Forward-Looking Statements
This communication contains forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements regarding the potential
transaction between Teladoc Health, Inc. (Teladoc) and Livongo Health, Inc. (Livongo), including any statements regarding the expected timetable for completing the potential transaction, the ability to complete the potential
transaction, the expected benefits of the potential transaction (including anticipated synergies, projected financial information and future opportunities) and any other statements regarding Teladocs and Livongos future expectations,
beliefs, plans, objectives, results of operations, financial condition and cash flows, or future events or performance. These statements are often, but not always, made through the use of words or phrases such as anticipate,
intend, plan, believe, project, estimate, expect, may, should, will and similar expressions. All such forward-looking statements are based on
current expectations of Teladocs and Livongos management and therefore involve estimates and assumptions that are subject to risks, uncertainties and other factors that could cause actual results to differ materially from the results
expressed in the statements. Key factors that could cause actual results to differ materially from those projected in the forward-looking statements include the ability to obtain the requisite Teladoc and Livongo stockholder approvals; uncertainties
as to the timing to consummate the potential transaction; the risk that a condition to closing the potential transaction may not be satisfied; the risk that the anticipated